Review on the pharmacological activities of anethole by Marinov, Veselin & Valcheva-Kuzmanova, Stefka
14  Scripta Scientifica Pharmaceutica, vol. 2, No. 2, 2015, pp. 14-19 
Copyright © Medical University of Varna
REVIEWS
REVIEW ON THE PHARMACOLOGICAL ACTIVITIES  
OF ANETHOLE
Veselin Marinov, Stefka Valcheva-Kuzmanova
Department of Preclinical and Clinical Pharmacology, Medical University of Varna
Address for correspondence:  
Veselin Marinov
Department of Preclinical and Clinical Pharmacology, 
Medical University of Varna
55 Marin Drinov Str.
9002 Varna, Bulgaria
e-mail: vesko12345v@gmail.com
Received: July 4, 2015
Accepted: December 1, 2015
PHYSICOCHEMICAL PROPERTIES 
OF ANETHOLE
The chemical structure of anethole is given in 
Fig. 1. Anethole exists as both cis and trans isomers, 
involving the double bond outside the ring. The more 
abundant isomer, and the one preferred for use, is the 
trans or E isomer.
Anethole is clear, colorless to amber liquid with 
a sweet anise-like flavor. Anethole is only slightly 
soluble in water but exhibits high solubility in eth-
anol. This difference causes certain anise-flavored 
liqueurs to become opaque when diluted with wa-
ter. This is due to the spontaneous formation of a 
microemulsion. 
Anethole is distinctly sweet, 13 times sweet-
er than sugar. It is used in many alcoholic drinks. It 
flavors Middle Eastern arak, Colombian aguardien-
te, French spirits absinthe, anisette and pastis, Greek 
ouzo, Bulgarian and Macedonian mastika, German 
Jägermeister, Italian sambuca, Dutch Brokmöpke, 
Portuguese, Peruvian, and Spanish anísado, Herbs 
de Majorca, Mexican Xtabentún and Turkish rakı. 
Anethole can cover unpleasant odours, so it 
is widely used as a masking agent in commodities, 
such as toilet soap, toothpaste, mouthwash, etc. This 
is the main use of anethole, about 80% of the total. It 
is used as a flavouring additive and scent in food in-
dustry products such as candy, baked goods, chew-
ing gum, cigarettes, etc.
ABSTRACT
In recent years there has been an increasing interest in the activities of phytopharmaceutical products 
and biologically active substances of plant origin. Anethole is such a substance used from ancient times 
in traditional medicine in many countries. Nowadays it is widely used in food and beverage industry. Its 
widespread use and accessible price justify carrying out extensive scientific research in order to support the 
traditional uses of anethole with scientific evidence. This review article summarizes the current knowledge 
of the traditional use of anethole, its pharmacological activities and the possible mechanisms underlying 
its effects. 
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Fig. 1. Chemical structure of anethole
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OCCURRENCE IN NATURE
Anethole is a type of aromatic compound that 
occurs widely in nature in essential oils. It contrib-
utes to the distinctive flavors of anise and fennel 
(both in the botanical family Apiaceae), anise myr-
tle (Myrtaceae), liquorice (Fabaceae), camphor, mag-
nolia blossoms, star anise (Illiciaceae) and many oth-
er plants. Natural anethole occurs in high concentra-
tions in anise oil (80-90%), star anise oil (over 90%) 
and fennel oil (80%). 
The essential oil in a plant has two types of 
function: protection and communication. It affords 
the host plant protection from pathogenic micro-
organisms such as viruses, bacteria and fungi, and/
or deters herbivorous animals from consuming the 
plant. The “fragrant cloud” surrounding the plant 
may attract a particular species of bee, for example, 
that will help the plant reproduce by cross-pollina-
tion when it visits similar plants. 
PHARMACOKINETICS OF 
ANETHOLE
Orally administered trans-anethole is rapidly 
absorbed, undergoes nearly complete metabolism in 
the liver producing metabolites that are conjugated 
and then excreted primarily in the urine. Some elim-
ination as CO
2
 in expired air also occurs. 
TRADITIONAL USE OF ANETHOLE
The medicinal use of aniseed is largely due to 
antispasmodic, secretolytic, secretomotor and an-
tibacterial effects of its essential oil. The tradition-
al uses of aniseed for “dyspeptic complaints such as 
mild, spasmodic gastro-intestinal ailments, bloating 
and flatulence“ and “catarrh of the upper respirato-
ry tract”. 
In folk medicine anise is used for upset stom-
ach, “runny nose” and as an expectorant to increase 
productive cough, as a diuretic to increase urine flow 
and as an appetite stimulant. Women use anise to in-
crease milk flow when nursing, start menstruation, 
treat menstrual discomfort or pain, ease childbirth 
and increase sex drive. Men use anise to treat symp-
toms of “male menopause.” Other uses include treat-
ment of seizures, nicotine dependence, trouble sleep-
ing (insomnia), asthma and constipation. Anise may 
be applied directly to the skin to treat lice, scabies 
and psoriasis.
On the basis of long-standing use and expe-
rience, the Committee on Herbal Medicinal Prod-
ucts of EMA recommends the following tradition-
al use indications for aniseed and anise oil: “Tradi-
tional herbal medicinal product: For symptomatic 
treatment of mild, spasmodic gastro-intestinal com-
plaints including bloating and flatulence; as an ex-
pectorant in cough associated with cold.” 
The above recommended indications are exclu-
sively based upon long-standing traditional use of 
aniseed. They are supported mainly by experimen-
tal data and by experts’ opinion, while no data from 




Fennel oil demonstrated antioxidant capaci-
ties as evaluated by two lipid model systems: a mod-
ified thiobarbituric acid reactive species assay and a 
spectrophotometric detection of hydroperoxydienes 
from linoleic acid in a micellar system, comparable 
to that of the reference antioxidants α-tocopherol and 
butilated hydroxytoluene. Water and ethanol extracts 
of fennel seeds showed 99.1 and 77.5% inhibition of 
peroxidation in linoleic acid system, greater than the 
same dose α-tocopherol (36.1%) (1) .
Anti-microbial, anti-fungal activity, antihel-
mintic and insecticidal activity
Anethole has potent antimicrobial properties, 
against bacteria, yeast and fungi. Both star anise es-
sential oil and all isolated compounds exhibit anti-
HSV-1 activity by direct inactivation of free virus 
particles in viral suspension assays. Star anise oil re-
duced viral infectivity by >99% (2).
An acetone extract of aniseed inhibited the 
growth of a range of bacteria including Escherich-
ia coli and Staphylococcus aureus and also exhibit-
ed antifungal activity against Candida albicans and 
other organisms (3).
Anise oil (0.2 %) alone showed an in vitro activ-
ity against Salmonella enteritidis. Aniseed essential 
oil inhibited the growth of Escherichia coli (minimal 
inhibitory concentration (MIC): 0.5%), Staphylococ-
cus aureus (MIC: 0.25%), Salmonella typhimurium 
(MIC: 2.0%) and Candida albicans (MIC: 0.5%) us-
ing the agar dilution method (4).
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In vitro, anethole has antihelmintic action on 
eggs and larvae of the sheep gastrointestinal nema-
tode Haemonchus contortus (5).
The insecticidal action of anethole is greater as 
a fumigant than as a contact agent. (E)-anethole is 
highly effective as a fumigant against the cockroach 
Blattella germanica. Anethole is an effective insect 
repellent against mosquitos (6).
Secretolytic and expectorant effects 
A solution of essential oil in 12% ethanol, ad-
ministered intra-gastrically to anaesthetized guinea 
pigs at 50 mg/kg b.w., induced a 3 to 6-fold increase 
in respiratory tract fluid during the first 2 hours after 
administration. A similar experiment in anaesthe-
tized rats, orally dosed with the oil at 0.0015 ml/kg, 
resulted in a 28% increase of respiratory tract fluid. 
Similar results were also observed in cats. An emul-
sion of 2 drops of the essential oil, administered in-
tragastrically to cats, caused hypersecretion of mu-
cus in the airways and stimulated ciliary removal of 
mucus, previously inhibited by opium alkaloids (7). 
An increase of about 12% in mucociliary transport 
velocity was observed 90 sec after the application of 
200 μl of an aniseed infusion (4.6 g per 100 ml of wa-
ter) to isolated ciliated epithelium of frog oesopha-
gus (8).
Spasmolytic effect on contracted smooth 
muscles 
Pharmacological data show a significant relax-
ing effect of aniseed alcoholic extracts and essential 
oil on tracheal and ileal smooth muscles contracted 
by several contraction-inducing agents (e.g. meta-
choline and carbachol) (9). 
Antinociceptive and anti-inflammatory 
activity
In the rabbit conjuctival reflex test, solutions of 
trans-anethole administered into the conjunctival 
sac increased concentration-dependently the num-
ber of stimuli required to evoke the conjuctival reflex 
(p<0.01); the effect was comparable to that of pro-
caine (10).
The effects of anethole in pain models of in-
flammatory origin was evaluated. Anethole (62.5, 
125, 250, and 500 mg/kg) showed an antinociceptive 
effect in the writhing model induced by intraperi-
toneal appication of acetic acid, in the second phase 
of the formalin-induced paw kicking test, in the test 
with glutamate injected under the ventral surface 
of the left hind paw, and pain induced by complete 
Freund adjuvant (CFA) injected into the plantar sur-
face of the hind paw. In contrast, anethole was not 
able to increase the latency time on the hot plate and 
decrease the number of flinches during the initial 
phase of the formalin test in any of the doses tested. 
The effect of anethole in pain models may be due to 
a decrease in the production/release of inflammato-
ry mediators (11).
Preincubation of ML1a cells (a Line of Human 
Myeloblastic Leukemia Cells) with anethole for 2 h 
resulted in decreased responses of these cells to the 
following treatment with TNF (12).
The effects of trans-anethole on IL-1ß and 
TNF-α level in a rat model of Eschericia coli lipo-
polysaccharide-induced periodontitis were investi-
gated in comparison with ketoprofen. Administra-
tion of either trans-anethole (10 or 50 mg/Kg, i.p.) or 
ketoprofen (10 mg/Kg, i.p.) resulted in a similar sup-
pression of IL-1ß and TNF-α production (13).
Anethole and estragole at a dose of 10 mg/kg 
were also tested in a model of paw edema induced by 
modulators or inflammatory mediators that partici-
pate in carrageenan-induced edema, such as brady-
kinin, histamine, serotonin, substance P, sodium ni-
troprusside. Anethole and estragole exhibited simi-
lar percent of inhibition of edema induced these sub-
stances: substance P (anethole: 64%, estragole: 67%), 
bradykinin (anethole: 41%, estragole: 42%), hista-
mine (anethole: 70%, estragole: 2%), TNF-α (ane-
thole: 34%, estragole: 44%). However, the percent in-
hibitions exhibited by these monoterpenes were dif-
ferentiated from each other in serotonin-induced 
edema (anethole: 55%, estragole: 30%). Moreover, 
only estragole (22%), but not anethole, exhibited an 
inhibitory effect to the sodium nitroprusside edem-
atogenic response (14).
The anti-inflammatory properties of anethole 
in animal models of nonimmune acute inflamma-
tion such as croton oil-induced ear edema and carra-
geenan-induced pleurisy were investigated. Oral ad-
ministration of anethole at a dose of 250 and 500 mg/
kg reduced both the volume of pleural exudates and 
the number of migrated leukocytes. The levels of ni-
tric oxide (NO) and prostaglandins (PGE
2
) in the in-
flammatory exudate were reduced by treatment with 
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anethole, but IL-1ß and TNF-α levels were not sig-
nificantly altered. In ear edema, the oral treatment 
with anethole inhibited the formation of exudate and 
the activity of myeloperoxidase. These results sug-
gest that the anethole may be effective in controlling 
some nonimmune acute inflammation-related dis-
ease, probably by an inhibitory action on production 
and/or release of PGE
2
 and NO (15).
Gastroprotective activity
Gastroprotective effects of F. vulgare essential 
oil and anethole at doses 50 and 100 mg/kg were in-
vestigated in ulcerogenesis induced by ethanol (90%, 
1 ml) in rats. Fennel oil and anethole exhibited a sig-
nificant gastroprotective activity against the erosive 
damage induced by ethanol. Their similar antiulcer 
activity could be attributed to the maintenance of a 
sufficient blood supply in the gastric mucosa through 
their antiplatelet and vasorelaxant effects. Indeed, 
they could prevent the disturbance in the gastric 
circulation generated by ethanol which caused a lo-
cal vasocongestion with vascular stasis and mucosal 
damage associated to overproduction of oxygen-de-
rived free radicals (16). Pretreatment with anethole 
(30 and 300 mg/kg) significantly increased mucus 
production by the gastric mucosa in the ethanol-in-
duced ulcer model (17).
Oral treatment with anethole at doses of 30, 
100, and 300 mg/kg, caused gastroprotection against 
ethanol- and indomethacin-induced gastric damage. 
Anethole did not reduce the lesion index in cold-re-
straint stress-induced ulcers in rats. 
The gastric ulcer protective potential of an 
aqueous suspension of the seeds of ‚Fennel‘ Foenic-
ulum vulgare (FVS) was evaluated against different 
acute gastric ulcer models in rats induced by pylor-
ic ligation (Shay), hypothermic restraint stress, indo-
methacin and necrotizing agents (80% ethanol, 0.2 
M NaOH and 25% NaCl). Fennel suspension, 250 
and 500 mg/kg administered orally (intraperitone-
ally in Shay rat model) showed dose-dependent ul-
cer protective effects in all the above models. Besides, 
FVS offered protection against ethanol-induced de-
pletion of gastric mucus; replenished the reduced 
nonprotein sulfhydryl concentration and modulated 
malondialdehyde contents in the gastric tissue. Etha-
nol induced histopathological lesions in the stomach 
wall characterized by mucosal hemorrhages and ede-
ma that was reversed by FVS. The gastro-protective 
efficacy of the FVS was probably due to its antisecre-
tory and antioxidant nature by which it strengthened 
mucosal defensive factors (18).
Anti-ulcerogenic and antioxidant effects of 
aqueous extracts of Foeniculum vulgare (FVE) on 
ethanol-induced gastric lesions in rats were evalu-
ated. FVE was administered by gavage at doses of 
75, 150 and 300 mg/kg, and famotidine (20 mg/kg) 
was used for comparison. Pre-treatment with FVE 
and famotidine were found to inhibit ethanol-in-
duced gastric mucosal injury. This protective effect 
of FVE was highest and statistically significant in the 
300 mg/kg group and higher than that in famotidine 
group. FVE showed an obvious gastroprotective ef-
fect and antioxidant properties (19).
Estrogenic effects 
Trans-anethole administered orally to imma-
ture female rats at 80 mg/kg for 3 days significantly 
increased uterine weight, to 2 g/kg compared to 0.5 
g/kg in controls and 3 g/kg in animals given estradiol 
valerate subcutaneously at 0.1 μg/rat/day (p<0.001). 
These results confirmed the estrogenic activity of 
trans-anethole. Other experiments showed that it 
had no anti-estrogenic, progestational, anti-proges-
tational, androgenic or anti-androgenic activity (20).
Estrogenic activity of trans-anethole at high 
concentrations has been determined by a sensitive 
and specific bioassay using recombinant yeast cells 
expressing the human estrogen receptor. Estrogen-
ic activity described for trans-anethole is not con-
firmed for aniseed alcoholic extracts on the basis of 
epidemiological data related to the common use of 
aniseed alcoholic beverages.
Reproductive toxicity 
Trans-anethole exerted a dose-dependent, an-
ti-implantation activity after oral administration to 
adult female rats on days 1-10 of pregnancy. When 
compared with control animals (all of which deliv-
ered normal offspring on completion of term), trans-
anethole administered at 50, 70 and 80 mg/kg inhib-
ited implantation by 33%, 66% and 100% respective-
ly. Further experiments were conducted with the 80 
mg/kg dose at different stages of pregnancy. When 
rats were administered trans-anethole on days 1-2 
of pregnancy, normal implantation and delivery oc-
curred; however rats administered anethole on days 
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3-5 of pregnancy, implantation was completely in-
hibited; and in those given trans-anethole on days 
6-10 of pregnancy three out of five rats failed to de-
liver at term. No gross malformations of offspring 
were observed in any of the groups. The results dem-
onstrated that trans-anethole has antifertility activ-
ity. From comparison with the days 1-2 group (lack 
of antizygotic activity), the lower level of delivery in 
the days 6-10 group was interpreted as a sign of early 
abortifacient activity (21).
Sedative activity
The pentobarbital-induced sleeping time of 
mice was increased by 93.5% after simultaneous in-
tra-peritoneal administration of essential oil at 50 
mg/kg; trans-anethole gave similar results (22).
SAFETY AND TOXICITY OF 
ANETHOLE
Anethole is associated with a slight increase in 
liver cancer in rats, although the evidence is scant 
and generally regarded as evidence that anethole is 
not a carcinogen. An evaluation of anethole by the 
Joint FAO/WHO Expert Committee on Food Addi-
tives (JECFA) found its notable pharmacologic prop-
erties to be reduction in motor activity, lowering of 
body temperature, and hypnotic, analgesic, and anti-
convulsant effects. At this time, the JECFA summa-
ry of these evaluations is that anethole has no safety 
concern at current levels of intake when used as a fla-
voring agent. In large quantities, anethole is slightly 
toxic and may act as an irritant. 
The council of Europe (1970) listed trans-ane-
thole giving an acceptable daily intakes of 1.5 mg/kg.
Oral LD
50
 values per kg b.w. were determined 
for the essential oil as 2.7 g in rats and for trans-ane-
thole as 1.8-5.0 g in mice; 2.1-3.2 g in rats; and 2.16 g 
in guinea pigs (23).
Mice were fed up to 240 mg trans-anethole/
kg/day with the diet for 90 days. Severe loss of body 
weight and dehydration were reported mainly at dos-
es of greater than or equal to 120 mg/kg/day and were 
attributed to the poor palatability of the diet and re-
duced food intake. Males fed orally with doses great-
er than or equal to 30 mg/kg/day showed increased 
absolute and relative liver weights, liver glycogen de-
pletion, increased relative thyroid weight. Anethole 
has a modest enzyme-inducing effect on mouse liv-
er (cytochrome P450 and P448). The increased liver 
weight was considered to be an adaptive physiologi-
cal response associated with the enzyme induction 
properties of trans-anethole, rather than an adverse 
effect (24).
ANETHOLE OVERDOSE 
Ingestion of 1 to 5 ml of anise oil in humans has 
been associated with nausea, vomiting, seizures and 
pulmonary edema.
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